About 100 reports

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Genome Sequencing Market Report The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021–2026. The global market is expected to grow due to the growing number of rare, terminal,...

  • Genome Sequencing
  • World
  • Cancer Incidence
  • Elderly Population

Abstract: - Global Single-Cell Genome Sequencing Market to Reach $3.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Single-Cell Genome Sequencing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at aCAGR of 14% over the period...

  • Genome Sequencing
  • World
  • China
  • United States

Abstract: - Global Genotyping Market to Reach $46.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain...

  • Genome Sequencing
  • Molecular Diagnostics
  • World
  • China
  • United States

SNP Genotyping market is one of the high-growth prospect industries with potential opportunities throughout 2028. The SNP Genotyping Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by SNP Genotyping types, applications. Further, SNP Genotyping market size...

  • Genome Sequencing
  • Genomics
  • World

The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies...

  • Genomics
  • Genome Sequencing
  • World
  • Europe
  • APAC
  • North America
  • Chronic Disease Prevalence
  • Final Consumption Expenditures

SNP Genotyping Market Report Overview SNP Genotyping market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across SNP Genotyping market types and applications. It is a focused study on SNP Genotyping market space including global and regional eight-year...

  • Genome Sequencing
  • World
  • Health Provider Density

Single Cell Genome Sequencing Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Single Cell Genome Sequencing market including the COVID-19 pandemic...

  • Genome Sequencing
  • APAC
  • Central America

Genotyping Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Genotyping market including the COVID-19 pandemic implications for Genotypings industry.The...

  • Genome Sequencing
  • APAC
  • Central America

Global Population Sequencing Market to Reach $64,047.6 Million by 2030 Market Report Coverage - Global Population Sequencing Market   Market Segmentation   • Product Type – Kits and Assays, Platforms, Software Tools • Application- Human Health, Molecular Forensics, Blockchain...

  • Genome Sequencing
  • World
  • Labour Force
  • Number Of Enterprises

Next Generation Sequencing Market, Global Forecast, Impact of COVID-19, Industry Trends, Growth, Opportunity By Types of Test, Company Analysis Next-generation sequencing refers to the deep, high-throughput, in-parallel DNA sequencing technologies developed a couple of decades after the Sanger DNA sequencing...

  • Molecular Diagnostics
  • Genome Sequencing
  • World
  • Health Expenditure

Forecasts by Technology (SBS, Ion Semiconductor Sequencing, Single Real Time Sequencing, Nanopore Sequencing and Other), by Products & Services (Instruments, Reagents & Consumables and Services), by Sequencing Tools (Illumina, Thermo Fischer, Oxford Nanopore, Pacific Biosciences and Other Platforms), by Reagents & Consumables, by Services...

  • Genome Sequencing
  • World
  • Asia
  • United States
  • Labour Force
  • Cancer Incidence

Market Overview The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market. The rapid speed, cost, and accuracy of the NGS...

  • Genome Sequencing
  • APAC
  • Europe
  • Africa
  • South America
  • Middle East
  • Drug Approval
  • Health Expenditure

Metagenomics Sequencing Market by Product & Service (Reagents & Consumables, Instruments, and Services), Technology (Shotgun Metagenomics Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing & De Novo Assembly, and Metatranscriptomics), and Application (Ecological & Environmental Metagenomics, Clinical Diagnostics, Drug Discovery,...

  • Genomics
  • Genome Sequencing
  • World

INTRODUCTION The field of genomic data collection and analysis has evolved significantly since the introduction of a gene sequencing method by Frederick Sanger in 1977. Advances in DNA sequencing technologies have led to significant developments in a variety of healthcare-focused research fields, such as precision medicine...

  • Genome Sequencing
  • World
  • APAC
  • Europe
  • North America

INTRODUCTION Advances in DNA sequencing technologies have led to significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Particularly, the impact of next generation sequencing (NGS) methods, enabling whole genome and whole exome sequencing, has been the most...

  • Genome Sequencing
  • World
  • APAC
  • Europe
  • North America

The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...

  • Healthcare
  • Therapy
  • Diagnostics
  • Genomics
  • Infectious Disease
  • Genome Sequencing
  • World
  • North America
  • APAC
  • Europe
  • Final Consumption Expenditures
  • Health Expenditure

Major players in the next generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc., Qiagen N.V., Hoffmann-La Roche AG, Eurofins Scientific, Oxford Nanopore Technologies, Pacific Biosciences, and 10x Genomics. The global next generation sequencing market is expected to grow from...

  • Genome Sequencing
  • World
  • APAC
  • Chronic Disease Prevalence

Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...

  • Genome Sequencing
  • Molecular Diagnostics
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Africa
  • Gross Domestic Product
  • Health Expenditure

Global Non-Invasive Prenatal Testing (NIPT) Market to Reach $12.61 Billion by 2031 Market Report Coverage - Non-Invasive Prenatal Testing (NIPT) Market Segmentation • By Test - Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony...

  • Healthcare
  • Genome Sequencing
  • Molecular Diagnostics
  • Diagnostics
  • Genetic Disorder
  • World

The global sequencing reagents market is expected to reach US$ 14,195.60 million by 2028 from US$ 5,530.32 million in 2020; it is estimated to grow at a CAGR of 12.5% from 2021 to 2028. The factors such as growing funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases drive the market growth....

  • Genome Sequencing
  • World
  • APAC
  • Europe
  • Chronic Disease Prevalence
  • Health Expenditure

The Asia Pacific digital genome market is expected to reach US$ 4,118.86 million by 2027 from US$ 2,077.27 million in 2019. The market is estimated to grow at a CAGR of 9.1% during 2020-2027. The digital genome market is growing primarily due to the increasing prevalence of chronic diseases and growing funding for genomics in the Asia Pacific...

  • Genome Sequencing
  • Diagnostics
  • Drug Development
  • Application
  • APAC
  • Chronic Disease Prevalence
  • Hospital Revenue

The global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 40.25 Billion by 2027, exhibiting a CAGR of 19.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...

  • Molecular Diagnostics
  • Genome Sequencing
  • World
  • Diabetes Prevalence

Global NGS Sample Preparation Market to Reach $3,279.3 Million by 2026 Market Report Coverage - NGS Sample Preparation Market Segmentation • Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components) • Workflow (Library Preparation, Target...

  • Genome Sequencing
  • Diagnostics
  • World
  • APAC

Epigenetics Market by Product (Kits, Reagents, Enzymes, and Instruments), Application (Oncology and Non-Oncology), and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2020–2027 The global epigenetics...

  • Pharmaceutical
  • Biotechnology
  • Drug Development
  • Genome Sequencing
  • RNAi Technology
  • World
  • Cancer Incidence

The digital genome market was valued at US$ 11,065.31 million in 2019 and is projected to reach US$ 20,812.81 million by 2027; it is expected to grow at a CAGR of 8.4% during 2020-2027. The growth of the digital genome market is mainly attributed to factors such as the increasing prevalence of chronic diseases and growing funding for genomics....

  • Genome Sequencing
  • Molecular Diagnostics
  • Infectious Disease
  • APAC
  • World
  • North America
  • Europe
  • Chronic Disease Prevalence
  • Cancer Incidence

Global Whole Genome and Exome Sequencing Market to Reach $7,303.0 Million by 2029 Market Report Coverage - Whole Genome and Exome Sequencing Market Segmentation • Product – Kits, Instruments • Workflow – Sample Extraction/Purification, Library Preparation, Library Quantification,...

  • Genome Sequencing
  • World

Single Cell Genome Sequencing Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Single Cell Genome Sequencing Market Size, Outlook and Growth Opportunities to 2025: By Produtc Type(Reagents, and Instruments),By Technology(Sequencing, qPCR, Microarray,MDA,and PCR), By Workflow( Single cell Isolation, Sample...

  • Genome Sequencing
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion.However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome...

  • Genetic Testing
  • Genome Sequencing
  • Direct-To-Retail
  • United States
  • European Union

The global array instruments market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 5.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...

  • Genomics
  • Genome Sequencing
  • Cytogenetic
  • Chronic Disease
  • World
  • Chronic Disease Prevalence

The Asia Pacific sequencing reagents market is expected to reach US$ 3,330.10 million by 2028 from US$ 1,392.13 million in 2021; it is estimated to grow at a CAGR of 13.3% from 2021 to 2028. The growth of the market is attributed to the increasing demand for third generation sequencing and personalized medicines. However, the dearth of skilled...

  • Genome Sequencing
  • APAC
  • Chronic Disease Prevalence
  • Cancer Incidence